PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2005; 26(01): 5-11
DOI: 10.1055/s-0041-1733103
Original Article

A Retrospective Non-Randomized Comparative Analysis of Experience with two Cisplatin Based Regimens in First Line Combination Chemotherapy for Advanced Non-Small Cell Lung Cancer

KONSTANTIN LAVRENKOV
Dept. of Oncology, Saroka University Medical Center, P.O. B15184101, Israel
,
DMITRI BOBILEV
Dept. of Oncology, Saroka University Medical Center, P.O. B15184101, Israel
,
LEONID BOGOMOLNI YORAM COHEN SAMUEL ARIAD
Dept. of Oncology, Saroka University Medical Center, P.O. B15184101, Israel
,
WILMOSH MERMERSHTAIN
Dept. of Oncology, Saroka University Medical Center, P.O. B15184101, Israel
› Author Affiliations
› Further Information
Also available ateRef
 PDF Download Permissions and Reprints
Preview Container


Publication History

Article published online:
28 March 2022

© 2005. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Jemal A., Thomas A., Murray T. et al. Cancer statistics, 2002. CA Cancer J. Clin. 2002;52:23-47.
  • 2 Shepherd F.A. Chemotherapy for non-small cell lung cancer: have we reached a new plateau? Semin. Oncol. 1999;26,suppl.4: 3-11.
  • 3 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data of individual patients from 52 randomized clinical trials. Brit. Med. J. 1995;311:899-909.
  • 4 Cardenal F., Lopez-Cabreizo M.P., Anton A. et al. Randomized phase III study of gemcitabine-cisplatin versus etoposidecisplatin the treatment of locally advanced or metastatic nonsmall cell lung cancer. J. Clin. Oncol. 1999;17:12-18.
  • 5 Bonomi P., Kim K., Fairclough D. et al. Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J. Clin. Oncol. 2000;18:623-631
  • 6 Wozniak A.J., Crowley J. J., Balkerzak S.P. et al. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a Southwest Oncology Group Study. J. Clin. Oncol. 1998;16:2459-2465.
  • 7 Sandler A.B., Nemunaitis J., Denham C. et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer. J. Clin. Oncol. 2000;18:122-130.
  • 8 Masuda N., Fukuoka M., Negoro S. et al. Randomized trial comparing cisplatin (CDDP) and irinotecan (CPT-11) vs CDDP and vindesine (VDS) vs CPT-11 alone in advanced non small cell lung cancer NSCLC, a multicenter phase III study. Proc. Am. Soc. Clin. Oncol. 1999;18:A492.
  • 9 Van Meerbeeck J.P., Smit E., Lianes P. et al. A EORTC randomized phase III trial of three chemotherapy regimens for advanced non small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol. 2001;20:A1228.
  • 10 Scaglioti G.V., Dmarinis F., Rinaldi M. et al. Phase III randomized trial comparing three platinum-based douplets in advanced non small cell lung cancer. Proc. Am. Soc. Clin. Oncol. 2001; 20: A309.
  • 11 Schiller J.H., Harrington D., Belani C.P. et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N. Engl. J. Med. 2002;346:92-98.
  • 12 Therasse P., Arbuck S., Eisenhauer E.A. et al. New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 2000;92:205-210.
  • 13 Kaplan E.I., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-481.
  • 14 Anderson H., Hopwood P., Stephens R.J. et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as primary outcome. Br. J. Cancer 2000;83:447-453.
  • 15 The Elderly Lung Cancer Vinorelbine Italian Study Group. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 1999;91:66-72.
  • 16 Ten Bokkel Huinink W.W., Bergman B., Chemaissani A. et al. Single agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced and metastatic non-small-cell lung cancer. Lung Cancer 1999;26:85-94.
  • 17 Perng R.P., Chen Y.M., Ming-Liu J. et al. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. J. Clin. Oncol. 1997;15:2097-2102.
  • 18 Vansteenkiste J., Vandebroak J., Nackaerts K. et al. Symptom control in advanced non-small cell lung cancer (NSCLC): a multicenter prospective randomized phase III study of single agent gemcitabine (GEM) versus cisplatin-vindesine (PV). Proc. Am. Soc. Clin. Oncol. 2000;19:A910.
  • 19 Le Chevalier T., Brisgand D., Duoillard J.Y. et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J. Clin. Oncol. 1994;12:360-367
  • 20 Grino L, Scagliotti G.V., Ricci S. et al. Gemcitabine and cisplatin versus mitomycin , ifosfamide, and cisplatin in advanced non-small cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. J. Clin. Oncol. 1999;17:3522-3530.
  • 21 K. Lavrenkov, L. Bogomolni and S.Ariad. Chemotherpy with gemcitabine and cisplatin for previously untreated patients with advanced non-small cell lung cancer. Oncology Forum, 2003;6(3):8-11.
  • 22 D. Bobilev, K. Lavrenkov, Y. Cohen and S. Ariad. Vinorelbine and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer. Oncology Forum, 2004;7(3):3-6.
  • 23 Kelly K., Crowley J., Bunn P.A. Jr. et al. randomized phase three trial of paclitaxel plus carboplatin vs vinorelbine plus cisplatin in the treatment of patients with advanced non small cell lung cancer. J. Clin. Oncol. 2001;19:3210-3218.
  • 24 Socinski M.A., Morris D.E., Masters G.A. and Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 2003; 123:226S-243S.